Companies / BridgeBio Pharma, Inc. / Activity
Activity — BridgeBio Pharma, Inc.
90 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Valantine Hannah Director | Sell | Common Stock | $624.3K | -9K -53.74% | 7,465 <0.01% of shares | medium |
| Mar 13, 2026 | Kumar Neil CEO | Sell | Common Stock | $662.4K | -10K -1.48% | 645,996 0.33% of shares | medium |
| Mar 13, 2026 | Kumar Neil CEO | Sell | Common Stock | $675.6K | -10K -0.22% | 4,438,447 2.27% of shares | medium |
| Mar 13, 2026 | Kumar Neil CEO | Sell | Common Stock | $700.3K | -10K -0.23% | 4,448,206 2.28% of shares | medium |
| Mar 13, 2026 | Kumar Neil CEO | Sell | Common Stock | $713.4K | -10K -1.60% | 635,686 0.33% of shares | medium |
| Feb 27, 2026 | Valantine Hannah Director | Sell | Common Stock | $739.5K | -11K -59.35% | 7,465 <0.01% of shares | medium |
| Jan 9, 2026 | Kumar Neil CEO | Sell | Common Stock | $816.4K | -11K -1.45% | 716,061 0.37% of shares | medium |
| Jan 9, 2026 | Kumar Neil CEO | Sell | Common Stock | $827.0K | -11K -0.24% | 4,520,302 2.31% of shares | medium |
| Jan 8, 2026 | Kumar Neil CEO | Sell | Common Stock | $848.0K | -12K -1.52% | 744,171 0.38% of shares | medium |
| Jan 8, 2026 | Kumar Neil CEO | Sell | Common Stock | $851.8K | -12K -0.25% | 4,546,882 2.33% of shares | medium |
| Mar 12, 2026 | Kumar Neil CEO | Sell | Common Stock | $950.7K | -14K -0.31% | 4,464,562 2.28% of shares | medium |
| Feb 27, 2026 | Valantine Hannah Director | Sell | Common Stock | $978.3K | -15K -44.26% | 18,365 <0.01% of shares | medium |
| Mar 12, 2026 | Kumar Neil CEO | Sell | Common Stock | $981.8K | -14K -2.12% | 661,349 0.34% of shares | medium |
| Feb 17, 2026 | Trimarchi Thomas Executive | Sell | Common Stock | $1.00M | -13K -3.83% | 336,785 0.17% of shares | medium |
| Feb 10, 2026 | Kumar Neil CEO | Sell | Common Stock | $1.01M | -14K -0.31% | 4,504,407 2.30% of shares | medium |
| Feb 10, 2026 | Kumar Neil CEO | Sell | Common Stock | $1.02M | -14K -1.98% | 701,485 0.36% of shares | medium |
| Feb 27, 2026 | Valantine Hannah Director | Exercise | Common Stock | $1.23M | +25K +341.38% | 32,949 0.02% of shares | low |
| Feb 19, 2026 | Kumar Neil CEO | Sell | Common Stock | $1.34M | -19K -7.21% | 243,581 0.12% of shares | medium |
| Feb 16, 2026 | Trimarchi Thomas Executive | Other | Common Stock | $1.42M | -19K -5.10% | 350,185 0.18% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Other | Common Stock | $2.33M | -31K -10.55% | 262,504 0.13% of shares | low |
| Mar 4, 2026 | Ellis Andrea Director | Sell | Common Stock | $4.21M | -65K -77.74% | 18,589 <0.01% of shares | medium |
| May 15, 2026 | Scott Randal W. Director | Exercise | Stock Option (Right to Buy) | — | -10K -31.75% | 21,501 0.01% of shares | low |
| Jun 22, 2026 | Aguiar Eric Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | McCormick Frank Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Momtazee James C Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Homcy Charles J Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Daniels Ronald J Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Jun 22, 2026 | Hassan Fred Director | Grant | Stock Option (Right to Buy) | — | +5K | 5,277 <0.01% of shares | low |
| Mar 17, 2026 | Kumar Neil CEO | Grant | Restricted Stock Units | — | +104K | 104,313 0.05% of shares | low |
| Mar 17, 2026 | Kumar Neil CEO | Grant | Stock Option (Right to Buy) | — | +41K | 40,570 0.02% of shares | low |
| Mar 10, 2026 | Valantine Hannah Director | Exercise | Stock Option (Right to Buy) | — | -9K -33.33% | 17,343 <0.01% of shares | low |
| Mar 4, 2026 | Ellis Andrea Director | Exercise | Stock Option (right to buy) | — | -65K -100.00% | 0 0.00% of shares | low |
| Feb 27, 2026 | Valantine Hannah Director | Exercise | Stock Option (Right to Buy) | — | -25K -100.00% | 0 0.00% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -12K -7.69% | 138,645 0.07% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -20K -11.11% | 156,794 0.08% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Restricted Stock Units | — | -34K -20.00% | 134,176 0.07% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +12K +4.10% | 293,474 0.15% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +20K +7.47% | 281,920 0.14% of shares | low |
| Feb 16, 2026 | Kumar Neil CEO | Exercise | Common Stock | — | +34K +14.66% | 262,320 0.13% of shares | low |
| Feb 17, 2026 | Scott Randal W. Director | Exercise | Stock Option (Right to Buy) | — | -10K -24.10% | 31,501 0.02% of shares | low |